Staph can lurk deep within nose

December 11, 2013, Stanford University Medical Center

Scientists at the Stanford University School of Medicine have revealed that formerly overlooked sites deep inside the nose may be reservoirs for Staphylococcus aureus, a major bacterial cause of disease.

The results of the study will be published Dec. 11 in Cell Host & Microbe.

The Stanford investigators further found an inverse relationship between the presence of S. aureus at these sites and that of a different bacterial species, Corynebacterium pseudodiphtheriticum, suggesting that the two organisms compete with each other and that C. pseudodiphtheriticum—or some molecular product it excretes—may prove useful in countering S. aureus infections.

"About one-third of all people are persistent S. aureus carriers, another third are occasional carriers and a remaining third don't seem to carry S. aureus at all," said David Relman, MD, the Thomas C. and Joan M. Merigan Professor and a professor of medicine and of microbiology and immunology. Relman, who is also chief of the infectious section at Veterans Affairs Palo Alto Health Care System, was the study's senior author. The lead author was Miling Yan, PhD, a graduate student in Relman's lab at the time the experiments were performed.

"The nose has been long known to be a primary reservoir of S. aureus," Relman said. The bug also abounds on the skin, with a special affinity for the armpits and groin. The vast majority of the time, however, it does little or no harm. (If it's doing any good, no one has figured out yet what that is, Relman added.)

But if the skin is compromised by, for example, a wound or a medical incision or catheter placement, S. aureus can get into the bloodstream and cause serious and even life-threatening problems such as sepsis, pneumonia or infection of heart valves. Close to half of all S. aureus strains are resistant to a family of antibiotics that includes methicillin. In 2011, more than 80,000 severe methicillin-resistant S. aureus infections, as well as more than 11,000 related deaths, occurred in the United States alone, along with a much higher number of less-severe infections.

"Not everyone who carries S. aureus gets sick," Relman said. "When they're out walking the streets and otherwise healthy, attempts to rid them of their S. aureus are not necessary, and even sometimes futile. But once a carrier enters a hospital with an underlying illness or a weakened immune system or a high likelihood of undergoing skin-penetrating procedures, S. aureus carriage is a major liability."

Rigorous and somewhat tedious regimens for eliminating S. aureus residing on people's skin or in their noses do exist, but it's typically a matter of weeks or months before the bacteria repopulate those who are susceptible. The new study offers a possible reason why this is the case.

The scientists recruited 12 healthy subjects and brought them to a Stanford ear, nose and throat clinic run by study co-author Peter Hwang, MD, professor of otolaryngology. Employing special instrumentation to allow them to guide tiny swabs to precise locations within the nose, they took samples from three specific areas. The first location—and far and away the most well-studied because it's much more accessible—was the anterior naris, a relatively dry skin-like patch of tissue located near the nostril. The second was the middle meatus—a warmer, wetter, mucus-producing fold found about midway up the nasal cavity. And the third was the sphenoethmoidal recess, situated deep within the cavity near the roof of the nose and, like the middle meatus, warm, wet and mucosal.

The researchers found that the presence or absence of S. aureus at one nasal site typically correlated with its presence or absence at the other two. An implication: If a person's anterior naris is carrying the bacteria, the upper mucosal areas probably are, too. This could be why efforts to banish S. aureus have so often proved short-lived. Focusing efforts largely on the bacteria in the anterior naris, which current decolonization procedures do, leaves deeper intact.

Relman's team learned three other things, as well. First, the relative abundance of S. aureus was inversely related to that of another bacterial species, C. pseudodiphtheriticum. When one was present at high levels, the other was present at low levels or absent. One of the study's co-authors, Sunje Pamp, PhD, a research associate in Relman's lab, put the two on an agar plate to scrutinize this relationship further, and found that C. pseudodiphtheriticum strongly blocked the growth of S. aureus.

The researchers suspect that something C. pseudodiphtheticum produces and secretes—perhaps a protein, or possibly a small molecule—is responsible for S. aureus' failure to thrive. If such a substance could be identified, Pamp said, it could provide clues to the development of new compounds to prevent or treat S. aureus infections.

Second, the microbial communities in those patients who harbor S. aureus differed in other ways from those in patients who don't. This could mean that S. aureus alters its environment to make it more or less hospitable to various other microbes. Or it could mean that different microbial communities are more or less hospitable to colonization by S. aureus. If the latter is the case, it may be possible to predict, based on their resident nasal microbes, which patients are most likely to be at high risk of a S. aureus infection—even if they're not currently carrying it—and monitor and treat them accordingly. Those patients found to be at lower risk could be spared such procedures.

Third, in the middle meatus and the sphenoethmoidal recess—the two deeper, wetter mucosal regions of the —microbial communities were similar to each another, but quite distinct from the one inhabiting the more accessible and better-studied outer site, the anterior naris. This suggests that currently routine methods of sampling the nasal cavity for microbe-research purposes may be yielding skewed results.

Explore further: Staphylococcus aureus: Why it just gets up your nose

Related Stories

Staphylococcus aureus: Why it just gets up your nose

December 27, 2012
A collaboration between researchers at the School of Biochemistry and Immunology and the Department of Microbiology at Trinity College Dublin has identified a mechanism by which the bacterium Staphylococcus aureus (S. aureus) ...

How the bacterium that plays role in spread of MRSA colonises the human nose

January 28, 2013
A collaboration between researchers at the School of Biochemistry and Immunology and the Department of Microbiology at Trinity College Dublin has identified a mechanism by which the bacterium Staphylococcus aureus (S. aureus) ...

Staphylococcus aureus bacteria turns immune system against itself

November 19, 2013
Around 20 percent of all humans are persistently colonized with Staphylococcus aureus bacteria, a leading cause of skin infections and one of the major sources of hospital-acquired infections, including the antibiotic-resistant ...

Pediatric musculoskeletal MRSA infections on the rise

October 26, 2013
Pediatric musculoskeletal Staphylococcus aureus bacterial infections have been evolving over the past decade, with more children diagnosed with the more virulent, methicillin-resistant Staphylococcus aureus (MRSA) today than ...

Vibativ approved for certain bacterial pneumonia

June 24, 2013
(HealthDay)—The antibiotic Vibativ (telavancin) has been approved by the U.S. Food and Drug Administration to treat pneumonia caused by Staphylococcus aureus bacteria when other treatments aren't suitable.

Long-term use of antibiotic to treat acne not associated with increased bacterial resistance

April 11, 2011
The prolonged use of tetracycline antibiotics commonly used to treat acne was associated with a reduced prevalence of StaphylococcuS. aureus bacteria and was not associated with increased resistance to the tetracycline antibiotics, ...

Recommended for you

Onions could hold key to fighting antibiotic resistance

January 22, 2018
A type of onion could help the fight against antibiotic resistance in cases of tuberculosis, a UCL and Birkbeck-led study suggests.

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.